Neutralizing antibodies against SARS-CoV-2 in Brazilian pregnant women vaccinated with one or two doses of BNT162b2 mRNA vaccine (Pfizer/WyethTM)
Pregnant women have an increased risk of developing severe coronavirus disease. In Brazil, the number of hospitalizations and adverse outcomes, including death caused by COVID-19, in women during the pregnancy-puerperal cycle was high in the first pandemic year. Doubts regarding vaccines' effic...
Saved in:
Main Authors: | Mauro César da Silva (Author), Neila Caroline Henrique da Silva (Author), Ana Laura Carneiro Gomes Ferreira (Author), Fernanda Carneiro Gomes Ferreira (Author), Maria Inês Bezerra de Melo (Author), Letícia Micherlyne Xavier da Silva (Author), Camila Rodrigues de Melo Barbosa (Author), Jurandy Júnior Ferraz de Magalhães (Author), George Tadeu Nunes Diniz (Author), Ariani Impieri Souza (Author), Norma Lucena-Silva (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neutrophilic urticarial dermatosis following BNT162b2 (Pfizer-BioNTech) COVID‐19 vaccination
by: Akihiro Matsubara, et al.
Published: (2021) -
Increased adverse events following third dose of BNT162b2/Pfizer vaccine in those with previous COVID-19, but not with concurrent influenza vaccine
by: Rachael K. Raw, et al.
Published: (2023) -
Increased adverse events following third dose of BNT162b2/Pfizer vaccine in those with previous COVID-19, but not with concurrent influenza vaccine.
by: Rachael K Raw, et al.
Published: (2023) -
Analysis of intracranial haemorrhage following tozinameran (BNT162b2, Pfizer-BioNTech)
by: Yohhei Hamada
Published: (2021) -
Recurrent erythema nodosum after the second dose of the Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccine
by: Xiaotian Wu, MBBS, MRCP, MMed, et al.
Published: (2022)